An obvious next step in the development and growth of CAR T-cell therapies has been the jump to solid tumors. Because of ...

T cells and allogeneic hematopoietic stem cell transplantation. Dr Simonetta's clinical work is mainly focused on Chimeric ...

Phase 1 Basket Study for B Cell-mediated Autoimmune Diseases to Assess FT522 as Add-on to Standard-of-care Induction and ...

Fate Therapeutics (FATE) presented initial clinical and translational data from the company’s Phase 1 study of FT522 in relapsed / refractory ...

E-mail: [email protected] Clin Cancer Res 2024;30:5083–93 H. Hubbeling and D. Leithner contributed equally and are co-first authors to this article. R. Shouval and B.S. Imber contributed equally and ...

The study demonstrates that activating the vitamin D receptor (VDR) with calcitriol suppresses cell proliferation in ...

Researchers develop a plug-and-play test that enables real-time monitoring of engineered T-cells, improving the precision and ...

remission among patients with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL), according to data collected from the Real World Outcomes Collaborative for chimeric antigen receptor (CAR ...

To develop the next generation of in vivo T cell therapy, Novartis will leverage Vyriad's active targeting lentiviral vector ...